n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with scopolamine hydrobromide in 5 studies
| Studies (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Trials (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Recent Studies (post-2010) (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 98 | 0 | 29 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maurice, T; Privat, A; Urani, A | 1 |
| Altar, CA; Kikuchi, T; Miwa, T; Nakai, M; Oshiro, Y; Tottori, K; Uwahodo, Y; Yamada, S | 1 |
| Hiramatsu, M; Hoshino, T; Kanematsu, K | 1 |
| Hiramatsu, M; Hoshino, T | 1 |
| Araki, H; Hato-Yamada, N; Su, J; Yoshimura, H | 1 |
5 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and scopolamine hydrobromide
| Article | Year |
|---|---|
The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (sigma1) receptors.
Topics: Animals; Anisoles; Dehydroepiandrosterone Sulfate; Learning Disabilities; Male; Maze Learning; Mice; Muscarinic Antagonists; Pregnenolone; Progesterone; Propylamines; Receptors, sigma; Scopolamine; Swimming | 1998 |
Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
Topics: Acetylcholine; Acetylcholinesterase; Aging; Animals; Anisoles; Avoidance Learning; Brain Chemistry; Cholinergic Agents; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Male; Maze Learning; Memory Disorders; Microdialysis; Muscarinic Antagonists; Piperazines; Propylamines; Quinolones; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, sigma; Scopolamine; Serotonin Receptor Agonists | 2002 |
Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
Topics: Animals; Anisoles; Antipsychotic Agents; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Morphine Derivatives; Narcotic Antagonists; Pain; Pain Measurement; Propylamines; Receptors, Opioid; Scopolamine; Statistics, Nonparametric | 2005 |
Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors.
Topics: Acetic Acid; Analgesics, Opioid; Analysis of Variance; Animals; Anisoles; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Isomerism; Male; Maze Learning; Memory Disorders; Mice; Naltrexone; Narcotic Antagonists; Pain Measurement; Pentazocine; Propylamines; Receptors, Opioid, kappa; Receptors, sigma; Scopolamine | 2005 |
Test-retest paradigm of the forced swimming test in female mice is not valid for predicting antidepressant-like activity: participation of acetylcholine and sigma-1 receptors.
Topics: Acetylcholine; Animals; Anisoles; Antidepressive Agents; Cholinergic Antagonists; Female; Forecasting; Imipramine; Mice; Mice, Inbred ICR; Motor Activity; Paroxetine; Propylamines; Receptors, sigma; Scopolamine; Stress, Psychological; Swimming | 2013 |